Sie befinden sich hier: Mitarbeiter > publist

Prof. Dr. h.c. Enno Christophers
Aktuelle Publikationen


Keine Einträge


Keine Einträge


Griffiths CE, Christophers E, Szumski A, Jones H, Mallbris L
Impact of early vs. Late disease onset on treatment response to etanercept in patients with psoriasis.
Br. J. Dermatol. 2015;173:1271-1273
Augustin M, Radtke MA, Glaeske G, Reich K, Christophers E, Schaefer I, Jacobi A.
Epidemiology and Comorbidity in Children with Psoriasis and Atopic Eczema.
Dermatology. 2015;231(1):35-40


Breitbart EW, Christophers E.
Arbeitsgemeinschaft Dermatologische Prävention (ADP) e. V.
J Dtsch Dermatol Ges 2014;12 Suppl 4:42


Christophers E, Segaert S, Milligan G, Molta CT, Boggs R.
Clinical improvement and satisfaction with biologic therapy in patients with severe plaque psoriasis: results of a European cross-sectional observational study.
J Dermatolog Treat 2013;24(3):193-8


Stockfleth E, Hinrichs B, Surber C, Christophers E.
Prevention initiative for dermatological malignancies: where do we stand?
Br J Dermatol 2012;167 Suppl 2:v-vi
Christophers E, Wenning J, Meurer M.
The Otto-Braun-Falco-Stipendium: A German-Polish success story
Hautarzt 2012;63 Suppl 1: 34-5
Choudhury K, Volkmer B, Greinert R, Christophers E, Breitbart EW.
Effectiveness of skin cancer screening programmes.
Br J Dermatol 2012;167 Suppl 2:94-8
Tsoi LC, Spain SL, Knight J, Ellinghaus E, Stuart PE, Capon F, Ding J, Li Y, Tejasvi T, Gudjonsson JE, Kang HM, Allen MH, McManus R, Novelli G, Samuelsson L, Schalkwijk J, Ståhle M, Burden AD, Smith CH, Cork MJ, Estivill X, Bowcock AM, Krueger GG, Weger W, Worthington J, Tazi-Ahnini R, Nestle FO, Hayday A, Hoffmann P, Winkelmann J, Wijmenga C, Langford C, Edkins S, Andrews R, Blackburn H, Strange A, Band G, Pearson RD, Vukcevic D, Spencer CC, Deloukas P, Mrowietz U, Schreiber S, Weidinger S, Koks S, Kingo K, Esko T, Metspalu A, Lim HW, Voorhees JJ, Weichenthal M, Wichmann HE, Chandran V, Rosen CF, Rahman P, Gladman DD, Griffiths CE, Reis A, Kere J; Collaborative Association Study of Psoriasis (CASP); Genetic Analysis of Psoriasis Consortium; Psoriasis Association Genetics Extension; Wellcome Trust Case Control Consortium 2, Nair RP, Franke A, Barker JN, Abecasis GR, Elder JT, Trembath RC.
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity.
Nat Genet. 2012;44(12):1341-8


Gahr N, Fölster-Holst R, Weichenthal M, Christophers E, Schröder JM, Bartels J
Dermal fibroblasts from acute inflamed atopic dermatitis lesions display increased eotaxin/CCL11 responsiveness to interleukin-4 stimulation
Br J Dermatol 2011;164:586-92
Sticherling M, Augustin M, Boehncke WH, Christophers E, Domm S, Gollnick H, Reich K, Mrowietz U.
Therapy of psoriasis in childhood and adolescence - a German expert consensus.
J Dtsch Dermatol Ges. 2011;Epub ahead of print


Gahr N, Fölster-Holst R, Weichenthal M, Christophers E, Schröder JM, Bartels J.
Dermal fibroblasts from acute inflamed atopic dermatitis lesions display increased Eotaxin/CCL11 responsiveness to IL-4 stimulation.
Br J Dermatol. 2010;doi: 10.1111/j.1365-2133


Dubertret L, Chimenti S, Christophers E, Daudén E, de Rie M, Griffiths CE, Kragballe K, Ståhle M, Stingl G.
Alice, Eloi, Magali and Robert: the lives of four patients with psoriasis and the therapeutic approaches of eight European experts.
Br J Dermatol 2009;161 Suppl 2: 1-30
Christophers E, Mrowietz U
In: Burgdorf WHC, Plewig G, Wolhh HH, Landthaler M: Braun-Falcos Dermatology, 3. Aufl. 2009;


Nair RP, Ruether A, Stuart PE, Jenisch S, Tejasvi T, Hiremagalore R, Schreiber S, Kabelitz D, Lim HW, Voorhees JJ, Christophers E, Elder JT, Weichenthal M,
Polymorphism of the IL12B and IL23R genes are associated with psoriasis.
J Invest Dermatol 2008;128:1653-61
Christophers E.
The founding of the European Skin Research Foundation (ESRF)
J Dtsch Dermatol Ges. 2008;6(5):341
Christophers E.
Explaining phenotype heterogeneity in patients with psoriasis.
Br J Dermatol 2008;158(3):437-41


Hügel R, Velasco P, De la Luz Sierra M, Christophers E, Schröder JM, Schwarz T, Tosato G, Lange-Asschenfeldt B
Novel anti-inflammatory properties of the angiogenesis inhibitor vasostatin
J Invest Dermatol 2007;127(1):65-74
Weichenthal M, Ruether A, Schreiber S, Nair R, Voorhees JJ, Schwarz T, Kabelitz D, Christophers E, Elder JT, Jenisch S.
Filaggrin R501X and 2282del4 mutations are not associated with chronic plaque-type psoriasis in a German cohort.
J Invest Dermatol. 2007;127(6): 1535-7
Christophers, E
Comorbidities in psoriasis
Clinic dermatol 2007;25(6):529-34
Griffiths CE, Christophers E, Barker JN, Chalmers RJ, Chimenti S, Krueger GG, Leonardi C, Menter A, Ortonne JP, Fry L
A classification of psoriasis vulgaris according to phenotype.
Br J Dermatol. 2007;156(2):258-62.
Christophers E
Comorbidities in psoriasis.
J Eur Acad Dermatol Venerol 2007;20:52-55
Christophers E
Defining psoriasis subtypes: features of severe psoriasis and associated diseases.
Expert Rev Dermatol 2007;2:1-5
Griffiths CE, Christophers E, Barker JN, Chalmers RJ, Chimenti S, Krueger GG, Leonardi C, Menter A, Ortonne JP, Fry L
A classification of psoriasis vulgaris according to phenotype.
Br J Dermatol 2007;156(2):258-62.
Christophers E
Psoriasis comorbidities reflect distinct mechanism of disease.
G Ital Dermatol Venerol 2007;142:513-158


Fölster-Holst R, Muller F, Schnopp N, Abeck D, Kreiselmaier I, Lenz T, von Ruden U, Schrezenmeir J, Christophers E, Weichenthal M.
Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis.
Br J Dermatol. 2006;155(6):1256-61
Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M.
Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis.
Arch Dermatol Res 2006;392:321-328
Nair RP, Stuart PE, Nistor I, Hiremagalore R, Chia NV, Jenisch S, Weichenthal M, Abecasis GR, Lim HW, Christophers E, Voorhees JJ, Elder JT.
Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene.
Am J Hum Genet 2006;78:827-851
Fölster-Holst R, Pape M, Buss YL, Christophers E, Weichenthal M.
Low prevalence of the intrinsic form of atopic dermatitis among adult patients.
Allergy 2006;61:629-632
Jenisch S, Hampe J, Elder JT, Nair R, Stuart P, Voorhees JJ, Schreiber S, Kabelitz D, Christophers E, Weichenthal M.
CARD15 mutations in patients with plaque-type psoriasis and psoriatic arthritis: lack of association.
Arch Dermatol Res 2006;297:409-411


Gläser R, Harder J, Lange H, Bartels J, Christophers E, Schröder JM
Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection
Stuart P, Nair RP, Abecasis GR, Nistor I, Hiremagalore R, Chia NV, Qin ZS, Thompson RA, Jenisch S, Weichenthal M, Janiga J, Lim HW, Christophers E, Voorhees JJ, Elder JT
Analysis of RUNX1 Binding Site and RAPTOR Polymorphisms in Psoriasis: No Evidence for Association Despite Adequate Power and Evidence for Linkage
Elder JT, Nair RP, Weichenthal M, Stuart P, Voorhees JJ, Christophers E, Jenisch S
The MHC Genes in Psoriasis
Current Genomics 2005;6:39-43
Elder JT, Abecasis G, Allen M, Barker JNWN, Burden D, Capon F, Christophers E, Fischer J, Giardina E, Gudjonsson JE, Hüffmeier U, Jenisch S, Karason A, Kere J, Nair RP, Sanchez F, Stahle M, Stuart P, Tillman D, Traupe H, Veal C, Voorhees JJ, Weichenthal
Fine Mapping of the Psoriasis Susceptibility Gene PSORS1: A Reassessment of Risk Associated with a Putative Risk Haplotype Lacking HLA-Cw6
Nistor I, Nair RP, Stuart P, Hiremagalore R, Thompson RA, Jenisch S, Weichenthal M, Abecasis GR, Qin ZS, Christophers E, Lim HW, Voorhees JJ, Elder JT
Protein tyrosine phosphatase gene PTPN22 polymorphism in psoriasis: lack of evidence for association.
van de Kerkhof P, Griffiths CE, Christophers E, Lebwohl M, Krueger GG
Alefacept in the treatment of psoriasis in patients for whom conventional therapies are inadequate.
DERMATOLOGY 2005;211:256-263
Fölster-Holst R, Stoll M, Koch WA, Hampe J, Christophers E, Schreiber S.
Lack of association of SPINK5 polymorphisms with nonsyndromic atopic dermatitis in the population of Northern Germany.
Brandt O, Christophers E, Fölster-Holst R.
Halo dermatitis followed by the development of vitiligo associated with Sutton's nevi.
Christophers, E, Mrowietz, U
In: Braun-Falco et al., Dermatologie und Venerologie, Springer-Verlag, Heidelberg, 5. Auflage 2005;
Christophers, E., Mrowietz, U.
In: Braun-Falco et al., Dermatologie und Venerologie, Springer-Verlag, Heidelberg, 5. Auflage. 2005;


Folster-Holst R, Weichenthal M, Steinsland K, Polzhofer G, Christophers E
Eczema infantum and its prognosis
Stockfleth E, Christophers E, Benninghoff B, Sterry W
Low incidence of new actinic keratoses after topical 5% imiquimod cream treatment: a long-term follow-up study
ARCHIVES OF DERMATOLOGY 2004;140:1542-1543
Sterry W, Barker J, Boehncke WH, Bos JD, Chimenti S, Christophers E, De La Brassinne M, Ferrandiz C, Griffiths C, Katsambas A, Kragballe K, Lynde C, Menter A, Ortonne JP, Papp K, Prinz J, Rzany B, Ronnevig J, Saurat JH, Stahle M, Stengel FM, Van De Kerkhof P, Voorhees J
Biological therapies in the systemic management of psoriasis: International Consensus


Schmook T, Stockfleth E, Lischner S, Gahn B, Christophers E, Hauschild A
Remarkable remission of a follicular lymphoma treated with rituximab and polychemotherapy (CHOP).
Paul CF, Ho VC, McGeown C, Christophers E, Schmidtmann B, Guillaume JC, Lamarque V, Dubertret L
Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study.
Lebwohl M, Christophers E, Langley R, Ortonne JP, Roberts J, Griffiths CE
An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis
Meyer T, Arndt R, Nindl I, Ulrich C, Christophers E, Stockfleth E
Association of human papillomavirus infections with cutaneous tumors in immunosuppressed patients.
Dunsche A, Kastel I, Terheyden H, Springer IN, Christophers E and Brasch J
Oral lichenoid reactions associated with amalgam: improvement after amalgam removal
Brasch J, Kreiselmaier I and Christophers E
Inhibition of dermatophytes by optical brighteners.
MYCOSES 2003;46:120-125
Ghoreschi K, Thomas P, Breit S, Dugas M, Mailhammer R, van Eden W, van der Zee R, Biedermann T, Prinz J, Mack M, Mrowietz U, Christophers E, Schlondorff D, Plewig G, Sander CA AND Röcken M
Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease
NATURE MEDICINE  2003;9:40-46
Christophers E
Targeting T-cell subsets to achieve remission.
Hauschild A, Christophers E
In: Onkologische Therapie. Hrsg.: Bruhn D, Fölsch UR, Kneba M, Löffler H. Schattauer, Stuttgart. 2003;
Christophers, E., Mrowietz, U.
Pustular eruptions of palms and soles.
In: Freedberg I.M., Eisen, A. Z., Wolff, K., Austen, K. F., Goldsmith, L. A., Katz, S. I. (Editors), Dermatology in general medicine, 6th edition 2003, Mc Graw-Hill, New York. 2003;
Christophers E, Mrowietz U
In: Freedberg I.M., Eisen, A. Z., Wolff, K., Austen, K. F., Goldsmith, L. A., Katz, S. I. (Editors), Dermatology in general medicine, 6th edition 2003, Mc Graw-Hill, New York. 2003;


Chuong, C.M., Nickoloff, B.J., Elias, P.M., Goldsmith, L.A., Macher, E., Maderson, P.A., Sundberg, J.P., Tagami, H., Plonka, P.M., Thestrup-Pederson, K., Bernard, B.A., Schroder, J.M., Dotto, P., Chang, C.M., Williams, M.L., Feingold, K.R., King, L.E., Kligman, A.M., Rees, J.L., Christophers, E.
What is the 'true' function of skin?
Eiling, S., Lischner, S., Rosien, F., Haacke, T.C., Schafer, F., Christophers, E., Hauschild, A.
Temozolomid als Therapieoption bei fernmetastasierten Melanompatienten mit ungünstiger Prognose.
HAUTARZT 2002;53:659-665
Gollnick, H., Altmeyer, P., Kaufmann, R., Ring, J., Christophers, E., Pavel, S., Ziegler, J.
Topical calcipotriol plus oral fumaric acid is more effective and faster acting than oral fumaric acid monotherapy in the treatment of severe chronic plaque psoriasis vulgaris.
DERMATOLOGY 2002;205:46-53
Guo, S.W., Jenisch, S., Stuart, P., Lange, E.M., Kukuruga, D., Nair, R., Henseler, T., Voorhees, J., Christophers, E., Elder, J.T.
Combined segregation and linkage analysis of HLA markers in familial psoriasis.
Kromminga, A., Sitaru, C., Meyer, J., Arndt, R., Schmidt, E., Christophers, E., Brocker, E.B., Zillikens, D.
Cicatricial pemphigoid differs from bullous pemphigoid and pemphigoid gestationis regarding the fine specificity of autoantibodies to the BP180 NC16A domain.
Meyer, T., Hauschild, A., Kromminga, A., Hartlepp, J., Arndt, R., Christophers, E., Stockfleth, E.
Clinical evaluation of 5-S-Cysteinyldopa testing using a new and optimized detection system as a tumour marker for malignant melanoma.
MELANOMA RESEARCH 2002;12:471-477
Orfanos, C.E., Christophers, E.
From dermatology into cosmetics. Chance or risk?
HAUTARZT 2002;53:1-4
Steude, J., Kulke, R., Christophers, E.
The role of the Duffy antigen-related chemokine receptor in psoriasis vulgaris.
CYTOKINE 2002;18:329-333
Stockfleth, E., Meyer, T., Benninghoff, B., Salasche, S., Papadopoulos, L., Ulrich, C., Christophers, E.
A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses.
ARCHIVES OF DERMATOLOGY 2002;138:1498-1502
Stockfleth, E., Ulrich, C., Hauschild, A., Lischner, S, Meyer, T., Christophers, E.
Successful treatment of basal cell carcinomas in a nevoid basal cell carcinoma syndrome with topical 5% imiquimod. A report of 3 cases.
Stockfleth, E., Ulrich, C., Meyer, T., Christophers, E.
Epithelial malignancies in organ transplant patients: clinical presentation and new methods of treatment.
Recent Results Cancer Res 2002;62:2004-2012
Stuart, P., Malick, F., Nair, R.P., Henseler, T., Lim, H.W., Jenisch, S., Voorhees, J., Christophers, E., Elder, J.T.
Analysis of phenotypic variation in psoriasis as a function of age at onset and family history.
Thaci, D., Brautigam, M., Kaufmann, R., Weidinger, G., Paul, C., Christophers, E.
Body-weight-independent dosing of cyclosporine micro-emulsion and three times weekly maintenance regimen in severe psoriasis. A randomised study.
DERMATOLOGY 2002;205:383-388
Ulrich, C., Christophers, E., Sterry, W., Meyer, T., Stockfleth, E.
Skin diseases in organ transplant patients.
HAUTARZT 2002;53:524-533
Foelster-Holst, R., Henseler, T., Wehde, J., Lemke, H., Weichenthal, M., Christophers, E., Hansen, H.P.
Soluble CD30 plasma concentrations correlate with disease activity in patients with atopic dermatitis.
Eiling, S., Lischner, S., Busch, J.O., Rothaupt, D., Christophers, E., Hauschild, A.
Complete remission of a radio-resistant cutaneous angiosarcoma of the scalp by systemic treatment with liposomal doxorubicin.
Frick S, Lischner S, Rosien F, Haacke TC, Schafer F, Christophers E, Hauschild A
Temozolomid als Therapieoption bei Patienten mit fernmetastasiertem Melanom und ungünstiger Prognose
Hautarzt 2002;53(10):659-65




Praktikum Dermatologie

Dermatologie für das Sommersemester 2021

Informationen zur Durchführung unter den Bedingungen der Virusepidemie fienden Sie -> HIER  

Dermatologie für Zahnmediziner

Dermatologie für Zahnmediziner Sommersemester 2021

Informationen zur Durchführung unter den Bedingungen der Virusepidemie folgen.. 


Die Seite wurde zuletzt am 11.05.2021 um 07:58 geändert.